ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

Market Cap	3.67B
Revenue (ttm)	535.62M
Net Income (ttm)	85.38M
Shares Out	112.42M
EPS (ttm)	0.76
PE Ratio	42.90
Forward PE	23.81
Dividend	0.20 (0.63%)
Ex-Dividend Date	Jun 14, 2024

Volume	669,150
Average Volume	6,204,488
Open	32.38
Previous Close	31.99
Day's Range	31.92 - 32.59
52-Week Range	19.40 - 36.98
Beta	0.69
RSI	68.05
Earnings Date	Apr 25, 2025

About ChengDu ShengNuo Biotec

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,128
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688117

Financial Performance

In 2024, ChengDu ShengNuo Biotec's revenue was 456.07 million, an increase of 4.84% compared to the previous year's 435.02 million. Earnings were 50.02 million, a decrease of -28.88%.